S2036 — Classifies xylazine as Schedule III controlled dangerous substance under certain circumstances.

S2036 — Classifies xylazine as Schedule III controlled dangerous substance under certain circumstances. · Informed CitizenrySenate Bill 2036 proposes classifying the drug xylazine, a non-opioid sedative increasingly linked to overdose deaths, as a Schedule III controlled dangerous substance when used in certain situatio…Open in Informed Citizenry